Provided by Tiger Trade Technology Pte. Ltd.

PGIM Corporate Bond 10+ Year ETF

50.88
0.0000
Volume:1.00
Turnover:50.61
Market Cap:76.32M
PE:- -
High:50.88
Open:50.88
Low:50.88
Close:50.88
52wk High:52.05
52wk Low:49.72
Shares:1.50M
Float Shares:1.50M
Volume Ratio:6.09
T/O Rate:0.00%
Dividend:1.15
Dividend Rate:2.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Phillip Securities Upgrades SCB X PCL to Buy from Accumulate, Price Target is THB145

MT Newswires Live
·
Feb 04

Press Release: EQB reports fourth quarter and fiscal 2025 results

Dow Jones
·
Dec 04, 2025

Table: PCL Technologies 3Q Net Profit NT$80.4M Vs NT$89.2M

Dow Jones
·
Nov 13, 2025

Press Release: Seaport Entertainment Group Reports Third Quarter 2025 Results

Dow Jones
·
Nov 11, 2025

Krungsri Securities Upgrades VGI PCL to Buy from Neutral; Price Target is THB1.41

MT Newswires Live
·
Nov 06, 2025

KGI Securities Upgrades BBGI PCL to Outperform from Neutral; Price Target is THB3.80

MT Newswires Live
·
Nov 05, 2025

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR FIRST QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, OCTOBER 23, AT 9:30 AM CENTRAL TIME

GlobeNewswire
·
Oct 23, 2025

HAO TIAN INTL (01341) Completes the Issuance of 1.6 Billion Consideration Shares to PCL

Stock News
·
Oct 22, 2025

Hong Kong Stock Movement | HAO TIAN INTL (01341) Surges Over 13% in Late Trading on New Share Issuance to Acquire PCL Stake, PLANETREE INT'L to Become Largest Shareholder

Stock News
·
Sep 25, 2025

Hong Kong Stock Alert | HAO TIAN INTL (01341) Drops Over 10% Again as Company Plans to Issue 1.6 Billion Consideration Shares at 7.41% Discount for PCL Subscription

Stock News
·
Sep 19, 2025

Hao Tian International Announces Major Share Subscription with PCL

TIPRANKS
·
Sep 17, 2025

Table: PCL Technologies 2Q Net Profit NT$301.0M Vs Net Loss NT$1.57M

Dow Jones
·
Aug 28, 2025

Press Release: BMO Financial Group Reports Third Quarter 2025 Results

Dow Jones
·
Aug 26, 2025

Press Release: CARsgen Therapeutics Announces 2025 Interim Results

Dow Jones
·
Aug 15, 2025